Identification of potent small molecule inhibitors of SARS-CoV-2 entry

This publication has 58 references indexed in Scilit:

• Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
  Journal of Virology, 2012
• The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice
  Clinical and Experimental Immunology, 2010
• Calpain inhibition preserves myocardial structure and function following myocardial infarction
  American Journal of Physiology-Heart and Circulatory Physiology, 2009
• Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide
  Journal of Virology, 2008
• Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• RETRACTED: Spike protein of SARS‐CoV stimulates cyclooxygenase‐2 expression via both calcium‐dependent and calcium‐independent protein kinase C pathways
  The FASEB Journal, 2007
• Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2
  Journal of Virology, 2004
• Improved Statistical Methods for Hit Selection in High-Throughput Screening
  SLAS Discovery, 2003
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
  SLAS Discovery, 1999
• Synthesis of a new cell penetrating calpain inhibitor (calpeptin)
  Biochemical and Biophysical Research Communications, 1988